Pruritus
Not yet recruitingEfficacy and safety of remibrutinib, pimecrolimus and tacrolimus in adults with severe chronic pruritus of unknown origin (CPUO): a randomized, placebo‑controlled trial
Efficacy and safety of remibrutinib, pimecrolimus and tacrolimus in adults with severe chronic pruritus of unknown origin (CPUO): a randomized, placebo‑controlled trial
- Disease:Pruritus
- Substances:PimecrolimusRemibrutinib+1
Portugal- Participants:18–64 years · 65+ years
- Substances:Pimecrolimus
- Sponsor:Novartis Pharma AG








